Both STAT5A and STAT5B are key tumor growth stimulators, but STAT5B overexpression seems to be more significant in head and neck and prostate cancers, while STAT5A – in breast cancer [31], [34], [35]. This evidence concerns the gene STAT5A and Familial prostate cancer.